IDDF2019-ABS-0258 Role of wearable technology on chronic liver disease in type 2 diabetic patients

Abstract

Background New wearable sensor networks together with smartphone applications are being examined and tested for their potential to monitor and manage chronic liver disease (CLD) in type 2 diabetic patients. To develop methods for analyzes and monitor of map the intersection(s) of hepatology data in relation to CLD via wearable technology (MI band and Yu band). To study effects of daily life routine activities on data by wearable devices that can obtain real-time CLD data, help technologists understand medical aspects, and clinicians to understand technological processes them and provide assistance based on pre-determined specifications in CLD in type 2 diabetic patients in New Delhi, India. Methods Total of 106 CLD with type 2 diabetes patients were taken as the subject with an equal ratio of male and female. Wearable monitoring devices were put on the wrist of CLD patients for 30 days and a questionnaire was filled out by each patient. Both diabetes and cardiovascular disease, in turn, are known as important factors for developing CLD and aggravation toward once end-stage liver disease. In all subjects, blood glucose was measured on a daily basis with day to day data of their monitoring of step count (deep sleep, light sleep, wake up time), blood pressure, calorie burnt, insulin dose, motion time i.e., every time when your body was in motion, sleep monitoring, monitoring heart rate, cardiac arrhythmias to know daily routines and recording them for health purpose. Results Present results showed that both wearable device readings showed there was a normal heart rate, more calorie burnt with better control of sugar control and average good sleep count in more physically workout, include walking in CLD patients compared to less physically workout CLD patients, identified by professional physiotherapists. Both device readings showed that after changing lifestyle routine among less physically active CLD patients, their post- CLD events normalize with less requirement of medicine and insulin injection dose. Conclusions With this study we show that, by using, these wearable devices ensured online assistive feedback for CLD patients with type 2 diabetes is possible with their health awareness, exercising and motivate further studies.